{"id":"https://openalex.org/W3094809299","doi":"https://doi.org/10.1182/blood-2020-140078","title":"Recovery of Ocular Events with Longer-Term Follow-up in the DREAMMM-2 Study of Single-Agent Belantamab Mafodotin (Belamaf) in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)","display_name":"Recovery of Ocular Events with Longer-Term Follow-up in the DREAMMM-2 Study of Single-Agent Belantamab Mafodotin (Belamaf) in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)","publication_year":2020,"publication_date":"2020-11-05","ids":{"openalex":"https://openalex.org/W3094809299","doi":"https://doi.org/10.1182/blood-2020-140078","mag":"3094809299"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2020-140078","doi":"https://doi.org/10.1182/blood-2020-140078","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-140078","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023276777","display_name":"Sagar Lonial","orcid":"https://orcid.org/0000-0002-8322-9323","observed_orcids":["https://orcid.org/0000-0002-8322-9323"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sagar Lonial","raw_affiliation_strings":["Emory University, Winship Cancer Institute, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University, Winship Cancer Institute, Atlanta, GA","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022520524","display_name":"Ajay K. Nooka","orcid":"https://orcid.org/0000-0003-4165-6869","observed_orcids":["https://orcid.org/0000-0003-4165-6869"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ajay Nooka","raw_affiliation_strings":["Emory University, Winship Cancer Institute, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University, Winship Cancer Institute, Atlanta, GA","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024529148","display_name":"Praneetha Thulasi","orcid":"https://orcid.org/0000-0003-1722-0053","observed_orcids":["https://orcid.org/0000-0003-1722-0053"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4210094864","display_name":"Emory Eye Center","ror":"https://ror.org/00hr6kp69","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4210094864","https://openalex.org/I4210109911"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Praneetha Thulasi","raw_affiliation_strings":["Emory Eye Center, Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory Eye Center, Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4210094864"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064710410","display_name":"Ashraf Z. Badros","orcid":"https://orcid.org/0000-0003-1690-0188","observed_orcids":["https://orcid.org/0000-0003-1690-0188"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashraf Z. Badros","raw_affiliation_strings":["University of Maryland School of Medicine, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Maryland School of Medicine, Baltimore, MD","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085703282","display_name":"Bennie H. Jeng","orcid":"https://orcid.org/0009-0001-7259-0885","observed_orcids":["https://orcid.org/0009-0001-7259-0885"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bennie H. Jeng","raw_affiliation_strings":["Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, MD","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042432109","display_name":"Natalie S. Callander","orcid":"https://orcid.org/0000-0002-6975-1086","observed_orcids":["https://orcid.org/0000-0002-6975-1086"]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]},{"id":"https://openalex.org/I4210103341","display_name":"University of Wisconsin Carbone Cancer Center","ror":"https://ror.org/01e4byj08","country_code":"US","type":"funder","lineage":["https://openalex.org/I135310074","https://openalex.org/I2799905417","https://openalex.org/I4210103341","https://openalex.org/I4210132596"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Natalie S. Callander","raw_affiliation_strings":["Carbone Cancer Center, University of Wisconsin, Madison, WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carbone Cancer Center, University of Wisconsin, Madison, WI","institution_ids":["https://openalex.org/I135310074","https://openalex.org/I4210103341"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053731124","display_name":"Douglas Weston Sborov","orcid":"https://orcid.org/0000-0003-4268-2698","observed_orcids":["https://orcid.org/0000-0003-4268-2698"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas Sborov","raw_affiliation_strings":["Huntsman Cancer Institute, University of Utah, Salt Lake Cty, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute, University of Utah, Salt Lake Cty, UT","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068243879","display_name":"Brian E. Zaugg","orcid":"https://orcid.org/0000-0001-6381-937X","observed_orcids":["https://orcid.org/0000-0001-6381-937X"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian E. Zaugg","raw_affiliation_strings":["Moran Eye Center, University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moran Eye Center, University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082564837","display_name":"Rakesh Popat","orcid":"https://orcid.org/0000-0001-6553-4618","observed_orcids":["https://orcid.org/0000-0001-6553-4618"]},"institutions":[{"id":"https://openalex.org/I1340918713","display_name":"University College London Hospitals NHS Foundation Trust","ror":"https://ror.org/042fqyp44","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1340918713"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rakesh Popat","raw_affiliation_strings":["University College London Hospitals, NHS Foundation Trust, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London Hospitals, NHS Foundation Trust, London, United Kingdom","institution_ids":["https://openalex.org/I1340918713"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108620139","display_name":"Simona Degli Esposti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325675289","display_name":"Moorfields Eye Hospital NHS Foundation Trust","ror":"https://ror.org/03zaddr67","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325675289"]},{"id":"https://openalex.org/I4210088407","display_name":"NIHR Moorfields Biomedical Research Centre","ror":"https://ror.org/004hydx84","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I1325675289","https://openalex.org/I34931013","https://openalex.org/I4210088407","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Simona Degli Esposti","raw_affiliation_strings":["NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom","institution_ids":["https://openalex.org/I1325675289","https://openalex.org/I4210088407","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089647963","display_name":"Julie Byrne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie Byrne","raw_affiliation_strings":["GlaxoSmithKline, Upper Providence, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Upper Providence, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072021995","display_name":"Joanna Opali\u0144ska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joanna Opalinska","raw_affiliation_strings":["GlaxoSmithKline, Upper Providence, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Upper Providence, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047778089","display_name":"January Baron","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"January Baron","raw_affiliation_strings":["GlaxoSmithKline, Upper Providence, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Upper Providence, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081566117","display_name":"Trisha Piontek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Trisha Piontek","raw_affiliation_strings":["GlaxoSmithKline, Upper Providence, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Upper Providence, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112446960","display_name":"Ira V Gupta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ira Gupta","raw_affiliation_strings":["GlaxoSmithKline, Upper Providence, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Upper Providence, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021687613","display_name":"Reza Dana","orcid":"https://orcid.org/0000-0002-5732-5100","observed_orcids":["https://orcid.org/0000-0002-5732-5100"]},"institutions":[{"id":"https://openalex.org/I1287163989","display_name":"Massachusetts Eye and Ear Infirmary","ror":"https://ror.org/04g3dn724","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1287163989"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Reza Dana","raw_affiliation_strings":["Massachusetts Eye and Ear, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts Eye and Ear, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1287163989","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048976307","display_name":"Asim V. Farooq","orcid":"https://orcid.org/0000-0002-4309-3353","observed_orcids":["https://orcid.org/0000-0002-4309-3353"]},"institutions":[{"id":"https://openalex.org/I4210087865","display_name":"University of Chicago Medical Center","ror":"https://ror.org/0076kfe04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Asim Farooq","raw_affiliation_strings":["University of Chicago Medical Center, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago Medical Center, Chicago, IL","institution_ids":["https://openalex.org/I4210087865"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057911528","display_name":"Andrzej J. Jakubowiak","orcid":"https://orcid.org/0000-0002-2597-6822","observed_orcids":["https://orcid.org/0000-0002-2597-6822"]},"institutions":[{"id":"https://openalex.org/I4210087865","display_name":"University of Chicago Medical Center","ror":"https://ror.org/0076kfe04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrzej Jakubowiak","raw_affiliation_strings":["University of Chicago Medical Center, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago Medical Center, Chicago, IL","institution_ids":["https://openalex.org/I4210087865"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":16,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":1.1932,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.77777778,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":98},"biblio":{"volume":"136","issue":"Supplement 1","first_page":"26","last_page":"27"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.7675999999046326,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.7675999999046326,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.2296999990940094,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/belantamab-mafodotin","display_name":"belantamab mafodotin","score":0.9710000157356262},{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.8989999890327454},{"id":"https://openalex.org/keywords/ocular-toxicity","display_name":"ocular toxicity","score":0.7089999914169312},{"id":"https://openalex.org/keywords/corneal-disease","display_name":"corneal disease","score":0.8960000276565552},{"id":"https://openalex.org/keywords/best-corrected-visual-acuity","display_name":"best-corrected visual acuity","score":0.8759999871253967},{"id":"https://openalex.org/keywords/monomethyl-auristatin-f","display_name":"monomethyl auristatin F","score":0.8159999847412109},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9399999976158142},{"id":"https://openalex.org/keywords/b-cell-maturation-antigen","display_name":"BCMA","score":0.7839999794960022},{"id":"https://openalex.org/keywords/long-term-recovery","display_name":"long-term recovery","score":0.5400000214576721},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.7850000262260437},{"id":"https://openalex.org/keywords/dry-eye-disease","display_name":"dry eye","score":0.39100000262260437}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8776283860206604},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.6663402915000916},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.46369776129722595},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.44571495056152344},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3476569354534149},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32717016339302063},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2020-140078","doi":"https://doi.org/10.1182/blood-2020-140078","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-140078","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4205759708","https://openalex.org/W3197211833","https://openalex.org/W4310117565","https://openalex.org/W7108477782","https://openalex.org/W4310107882","https://openalex.org/W4379281001","https://openalex.org/W3168041049","https://openalex.org/W4386282116","https://openalex.org/W3198367048","https://openalex.org/W3097230553"],"abstract_inverted_index":{"Introduction:":[0],"Patients":[1],"with":[2,53,74,85,239,259,383,427,464,486,542,613],"heavily":[3,54],"pretreated":[4,55],"RRMM":[5,56],"have":[6],"a":[7,17,36,75,159,244,308,324,348,481,585],"poor":[8],"prognosis":[9],"(median":[10,70],"overall":[11],"survival":[12],"[OS]:":[13],"6-9":[14],"months)":[15,73],"and":[16,64,118,122,142,157,162,190,200,232,374,506,525,550,590,990],"need":[18],"for":[19,295,303,623],"novel,":[20],"well-tolerated":[21],"treatments":[22],"that":[23],"induce":[24],"lasting":[25],"responses":[26,66],"(Gandhi":[27],"Leukemia":[28],"2019;":[29],"Chari":[30],"NEJM":[31],"2019).":[32],"Belamaf":[33],"(GSK2857916)":[34],"is":[35,547,629],"first-in-class,":[37],"B-cell":[38],"maturation":[39],"antigen-targeting,":[40],"antibody-drug":[41],"conjugate":[42],"(ADC)":[43],"containing":[44],"monomethyl":[45],"auristatin":[46],"F":[47],"(MMAF).":[48],"In":[49,134,314,381,425,615],"DREAMM-2":[50],"(NCT03525678),":[51],"patients":[52,148,258,296,315,336,382,426,463,479,513,541,552,581,612,619],"who":[57],"responded":[58],"to":[59,144,178,243,284,357,369,458,561,594],"single-agent":[60,150,317],"belamaf":[61,151,298,318],"maintained":[62],"deep":[63],"durable":[65],"at":[67,140,264,430,474,530],"13-month":[68,309],"follow-up":[69,310,449,532,557],"OS:":[71],">13":[72],"manageable":[76],"safety":[77],"profile":[78],"(Lonial":[79],"ASCO":[80],"2020,":[81],"Poster":[82],"436).":[83],"Consistent":[84],"other":[86],"MMAF-containing":[87],"ADCs,":[88],"ocular":[89,292,358],"events":[90,100,184,218,278,359,386,429,467,473,511,591,632],"were":[91,138,176,185,207,219,360,468,572],"common":[92],"(Farooq":[93,332,377,421,494,533],"et":[94],"al.":[95],"Ophthal":[96,333,378,405,422,495,534],"Ther":[97,334,379,406,423,496,535],"2020).":[98,380,407,424,497,536],"These":[99,217],"included":[101,158],"keratopathy":[102,330,370,384,570,599],"(microcyst-like":[103],"epithelial":[104],"changes":[105,202],"[MECs]:":[106],"an":[107,720,835,1030],"eye":[108,136,256,326,576],"exam":[109,161,198,228,230,327],"finding":[110,328],"with/without":[111],"symptoms),":[112],"best-corrected":[113],"visual":[114,170],"acuity":[115,171],"(BCVA)":[116],"changes,":[117],"symptoms":[119,340],"(blurred":[120],"vision":[121,343,492],"dry":[123,345],"eye).":[124,289,353],"Longer-term":[125],"recovery":[126,415,520,529],"data":[127],"will":[128,633],"help":[129],"inform":[130],"management":[131],"strategies.":[132],"Methods:":[133],"DREAMM-2,":[135],"exams":[137],"conducted":[139],"baseline":[141,168],"prior":[143],"each":[145,367],"dose":[146,302],"in":[147,235,253,400,439,448,556,608,813,912,921,930,939,948,955,964,981,1006],"received":[149],"(2.5":[152],"or":[153,247,344,438,470,602,725,840,1035],"3.4":[154],"mg/kg":[155,300],"Q3W)":[156],"corneal":[160,183,197],"assessment":[163],"of":[164,270,276,329,416,462,489,521,580,611,723,794,805,817,825,838,847,996,1012,1033],"BCVA":[165,201,245,260,282,350,376,484,588,605],"change":[166,242],"from":[167,203,307,454,566,645,654],"(Snellen":[169],"[VA]).":[172],"Dose":[173,205],"modifications":[174,206],"(delays/reductions)":[175],"permitted":[177],"manage":[179],"these":[180,277,499,631],"events.":[181,614],"The":[182,396,441,597],"graded":[186],"per":[187,389],"the":[188,211,254,538,578,609],"Keratopathy":[189],"Visual":[191],"Acuity":[192],"(KVA)":[193],"scale,":[194],"which":[195],"combined":[196],"findings":[199],"baseline.":[204,240],"determined":[208],"based":[209],"on":[210,575,626,719,834,1029],"most":[212,418],"severe":[213],"KVA":[214],"scale":[215],"grade.":[216],"followed":[220,622],"until":[221],"recovery,":[222],"defined":[223,280],"as":[224,281],"any":[225,876,890],"Grade":[226,387,465],"1":[227,504,545,564],"findings/no":[229],"findings,":[231],"\u22641-line":[233],"decline":[234,351,606],"Snellen":[236],"VA":[237,273],"compared":[238],"A":[241],"20/50":[246,263,287],"worse":[248],"(ie,":[249],"limiting":[250],"driving":[251],"ability)":[252],"better-seeing":[255],"(in":[257],"better":[261,285],"than":[262,286],"baseline)":[265],"was":[266,279],"considered":[267],"one":[268],"definition":[269],"clinically":[271,482,586,603],"meaningful":[272,483,587,604],"decrease.":[274],"Recovery":[275],"improvement":[283],"(better-seeing":[288,352],"We":[290],"report":[291],"event":[293,398,420,505,524,601],"outcomes":[294],"receiving":[297,316,436,548],"2.5":[299,319],"(recommended":[301],"future":[304],"clinical":[305],"development)":[306],"post-hoc":[311],"analysis.":[312],"Results:":[313],"mg/kg,":[320],"72%":[321],"(68/95)":[322],"experienced":[323],"treatment-related":[325],"(MECs)":[331,571],"2020).Fewer":[335],"(56%;":[337],"53/95)":[338],"had":[339,393,413,471,480,503,509,514,519,528],"(eg,":[341],"blurred":[342,372],"eye)":[346],"and/or":[347],"\u22652-line":[349],"Treatment":[354],"discontinuations":[355],"due":[356,368,560],"rare":[361],"(3%":[362],"[3/95]":[363],"total;":[364],"1%":[365],"[1/95]":[366],"[MECs],":[371],"vision,":[373],"reduced":[375],"(MEC)":[385,600],"\u22652":[388],"KVA,":[390],"48%":[391,411],"(29/60)":[392,412],">1":[394],"event.":[395],"first":[397,523,598],"recovered":[399,472,607],"77%":[401],"(46/60;":[402],"Table;":[403],"Farooq":[404],"At":[408],"last":[409,431,475,531],"follow-up,":[410,432],"documented":[414],"their":[417,522],"recent":[419],"unrecovered":[428,543],"45%":[433],"(14/31)":[434],"are":[435,445,553,620],"treatment":[437,549,595],"follow-up.":[440,476],"remaining":[442,539],"55%":[443],"(17/31)":[444],"no":[446,487,554],"longer":[447,555],"(9":[450],"died;":[451],"4":[452,456],"withdrew":[453,565],"study;":[455],"lost":[457],"follow-up).":[459],"84%":[460],"(37/44)":[461],"3/4":[466],"improving":[469],"Seventeen":[477],"(18%)":[478],"decline,":[485,589],"reports":[488],"complete":[490],"permanent":[491],"loss":[493],"Of":[498,537],"patients,":[500],"76%":[501],"(13/17)":[502],"24%":[507],"(4/17)":[508],"2":[510,551],"(no":[512],">2":[515],"events).":[516],"82%":[517,526],"(14/17)":[518,527],"3":[540],"events,":[544],"patient":[546],"(1":[558],"died":[559],"disease":[562],"progression;":[563],"study).":[567],"Conclusions:":[568],"Though":[569],"frequently":[573],"observed":[574],"exam,":[577],"majority":[579,610],"did":[582],"not":[583],"experience":[584],"rarely":[592],"led":[593],"discontinuation.":[596],"this":[616],"ongoing":[617],"study,":[618],"being":[621],"recovery.":[624],"Based":[625],"experience,":[627],"it":[628],"anticipated":[630],"likely":[634],"recover":[635],"over":[636],"time.":[637],"Funding:":[638],"GSK":[639],"(205678);":[640],"drug":[641],"linker":[642],"technology":[643],"licensed":[644,653],"Seattle":[646],"Genetics;":[647],"mAb":[648],"produced":[649],"using":[650],"POTELLIGENT":[651],"Technology":[652],"BioWa.":[655],"Disclosures":[656],"Lonial:":[657],"Karyopharm:":[658,1025],"Consultancy;":[659,661,706,715,735,803,968,970,972,985,987,1010],"Sanofi:":[660,757],"Amgen:":[662,778,798],"Consultancy,":[663,671,678,684,692,700,708,729,737,741,744,753,758,761,769,774,779,785,831,852,857,860,868,882,896,900,1018,1026],"Honoraria,":[664,679,685,693,701,709,745,754,762,770,775,780,786,832,861,869,883,1027],"Other:":[665,672,680,686,694,702,710,746,843,862,870,884],"Personal":[666,673,681,687,695,703,711,747,844],"fees;":[667,682,704,712],"Onyx:":[668],"Honoraria;":[669,730,738,742,759,853,858,901,1019],"Takeda:":[670,752,859],"fees,":[674,688,696],"Research":[675,689,697,750,755,763,771,776,781,787,822,865],"Funding;":[676,690,698,751,756,764,772,777,782,866],"Novartis:":[677,908,984],"Janssen:":[683,773,830,867],"BMS:":[691],"GSK:":[699,802,881,971],"Abbvie:":[705],"Merck:":[707],"JUNO":[713],"Therapeutics:":[714,717],"TG":[716],"Membership":[718,833,1028],"entity's":[721,836,1031],"Board":[722,837,1032],"Directors":[724,839,1034],"advisory":[726,841,1036],"committees;":[727],"Millennium:":[728],"Genentech:":[731],"Consultancy.":[732,799],"Nooka:Spectrum":[733],"Pharmaceuticals:":[734],"Oncopeptides:":[736],"Adaptive":[739,767],"Technologies:":[740],"GlaxoSmithKline:":[743,915,958],"Fees:":[748],"Travel/accomodations/expenses,":[749],"Celgene:":[760],"Karyopharm":[765],"Therapeutics,":[766],"technologies:":[768],"Bristol-Myers":[783],"Squibb:":[784,856],"Funding.":[788,823],"Thulasi:Emory":[789],"University:":[790],"Current":[791,796,807,810,819,827,849,905,909,916,918,925,927,934,936,943,945,952,959,961,978,998,1003,1014],"Employment.":[792,850,906,1015],"Badros:University":[793],"Maryland:":[795,806],"Employment;":[797,808,820,828,999],"Jeng:Kedrion,":[800],"Merck,":[801],"University":[804,1011],"EyeGate:":[809],"equity":[811,910,919,928,937,946,953,962,979,1004],"holder":[812,911,920,929,938,947,954,963,980,1005],"publicly-traded":[814,913,922,931,940,949,956,965,1007],"company.":[815,923,932,941,950,966,1008],"Callander:University":[816],"Wisconsin:":[818],"Cellectar:":[821],"Sborov:University":[824],"Utah:":[826,848],"Celgene,":[829],"committees,":[842],"fees.":[845],"Zaugg:University":[846],"Popat:Celgene:":[851],"Bristol":[854],"Myers":[855],"Travel":[863],"support,":[864],"TRAVEL,":[871,885],"ACCOMMODATIONS,":[872,886],"EXPENSES":[873,887],"(paid":[874,888],"by":[875,889],"for-profit":[877,891],"health":[878,892],"care":[879,893],"company);":[880,894],"AbbVie:":[895],"Honoraria.":[897],"Degli":[898],"Esposti:GlaxoSmithKline:":[899],"Moorfields":[902],"Eye":[903,989],"Hospital:":[904],"Byrne:Adaptimmune,":[907],"company;":[914,957,983],"Employment,":[917,926,935,944,960],"Opalinska:GlaxoSmithKline:":[924],"Baron:GlaxoSmithKline:":[933],"Piontek:GlaxoSmithKline:":[942],"Gupta:Novartis:":[951],"Dana:Kala:":[967],"Alcon:":[969],"Aramis":[973],"Biosciences,":[974],"Claris":[975],"Biotherapeutics,":[976],"GelMEDIX:":[977],"private":[982],"Dompe:":[986],"Massachusetts":[988],"Ear;":[991],"Harvard":[992],"Medical":[993],"School":[994],"Department":[995],"Ophthalmology:":[997],"NIH,":[1000],"DOD,":[1001],"Allegan:":[1002],"Farooq:GlaxoSmithKline:":[1009],"Chicago:":[1013],"Jakubowiak:Adaptive,":[1016],"Juno:":[1017],"AbbVie,":[1020],"Amgen,":[1021],"BMS/Celgene,":[1022],"GSK,":[1023],"Janssen,":[1024],"committees.":[1037]},"counts_by_year":[{"year":2021,"cited_by_count":6}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2020-11-09T00:00:00"}